Akers Biosciences Inc (AKER)

0.366648 -0.00345 (-0.933%)

IEX Real-Time Price

July 20, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.3701

Price Open 0.375

Volume: 1.01M

Avg Volume: 2.5M

Market Cap: 34.5M

P/E Ratio -

52 Wk Range 0.122-1.82



AKER Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-06-29
81.12M
11.57M
2.51
14.27%

2018-06-15
81.12M
11.18M
1.40
13.79%

2018-05-31
81.12M
10.35M
1.29
12.76%

2018-05-15
81.12M
9.59M
2.18
11.82%




News

Akers Biosciences inks deal with Appleton Medical Services for heparin PF4 rapid test covering additional 12 states (2018-07-18 07:24 SeekingAlpha)

Akers Biosciences (NASDAQ: AKER ) announces agreement with Appleton Medical Services, based inSt. Louis, Missouri, adding sales and marketing coverage for the Companys rapid test for heparin-induced thrombocytopenia (HIT) across an additional 12 states. More news on: Akers …

 

DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Akers Biosciences, Inc. to Contact the Firm (2018-07-18 07:18 Business Wire)

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Akers Biosciences, Inc. (Nasdaq: AKER) (Akers…

 


Statistics

Shares Outstanding: 94.11M

Top 15 Institution Percent: 11.10

Price To Sales: 14.71

Price To Book: 3.05

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -60.93

Return On Equity: -70.83

Profit Margin: N/A

Price History

Beta: -115.94

50-day Moving Avg: 0.43

200-day Moving Avg: 0.52

YTD Change: 186.22

5-day Change: -3.49

1-month Change: -11.46

3-month Change: -31.43

6-month Change: 22.22

1-year Change: -68.12

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Akers Biosciences Inc

Exchange: NASDAQ Capital Market

Industry: Medical Instruments & Equipment

Sector: Healthcare

Website: http://www.akersbio.com

Akers Biosciences Inc mainly develops and manufactures rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a time- and cost-efficient manner.